Literature DB >> 1324417

Binding characteristics of the thyroid hormone receptor homo- and heterodimers to consensus AGGTCA repeat motifs.

G M Wahlström1, M Sjöberg, M Andersson, K Nordström, B Vennström.   

Abstract

Previous studies have shown that thyroid hormone receptors can form homo- and heterodimeric complexes when binding to response elements. We report here the binding characteristics of thyroid hormone receptor (TR) homo- and heterodimers binding to synthetic oligonucleotides with directly and palindromically repeated consensus motifs (AGGTCA). Binding assays showed that TR homodimer formation on DNA had a low specificity and cooperativity, and very fast off rates. In contrast, TRs and retinoic acid receptors readily formed heterodimers with higher specificity and affinity on direct repeats of the AGGTCA motif spaced by four or five nucleotides, although these heterodimer/DNA complexes were only moderately stable when compared to DNA-bound TR/retinoid X receptor heterodimers. Also, TR/retinoic acid receptor heteromeric binding to other elements, including the synthetic T3RE-pal element, was of low specificity. These biochemical results suggest that TRs are unlikely to regulate transcription as homodimers in vivo, and that TR heterodimers mediate the effects of thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324417     DOI: 10.1210/mend.6.7.1324417

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  28 in total

1.  Fundamentally distinct roles of thyroid hormone receptor isoforms in a thyrotroph cell line are due to differential DNA binding.

Authors:  Maria I Chiamolera; Aniket R Sidhaye; Shunichi Matsumoto; Qiyi He; Koshi Hashimoto; Tania M Ortiga-Carvalho; Fredric E Wondisford
Journal:  Mol Endocrinol       Date:  2012-05-08

2.  DNA bending by the silencer protein NeP1 is modulated by TR and RXR.

Authors:  R Arnold; M Burcin; B Kaiser; M Muller; R Renkawitz
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

3.  Identification and analysis of all components of a gel retardation assay by combination with immunoblotting.

Authors:  S Demczuk; M Harbers; B Vennström
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  DNA recognition by thyroid hormone and retinoic acid receptors: 3,4,5 rule modified.

Authors:  Theresa Q Phan; Margaret M Jow; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2009-11-27       Impact factor: 4.102

5.  The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences.

Authors:  S A Oñate; P Prendergast; J P Wagner; M Nissen; R Reeves; D E Pettijohn; D P Edwards
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

6.  The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.

Authors:  M Au-Fliegner; E Helmer; J Casanova; B M Raaka; H H Samuels
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Nuclear hormone receptors involved in neoplasia: erb A exhibits a novel DNA sequence specificity determined by amino acids outside of the zinc-finger domain.

Authors:  H Chen; Z Smit-McBride; S Lewis; M Sharif; M L Privalsky
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

8.  Coactivator recruitment is enhanced by thyroid hormone receptor trimers.

Authors:  Brenda J Mengeling; Sangho Lee; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2007-10-06       Impact factor: 4.102

9.  A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha.

Authors:  F X Claret; T Antakly; M Karin; F Saatcioglu
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

10.  Thyroid hormone receptor can modulate retinoic acid-mediated axis formation in frog embryogenesis.

Authors:  D E Banker; R N Eisenman
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.